@article{b3e839dc5f8c499dab2c282d13f9f2a2,
title = "Reply: empagliflozin effects on cardiac remodeling: re-shaping the future of heart failure prevention",
keywords = "Empagliflozin, adverse remodeling, cardiac fibrosis, heart failure, myocardial strain, type 2 diabetes mellitus",
author = "Alvaro Garcia-Ropero and Santos-Gallego, \{Carlos G.\} and Badimon, \{Juan J.\}",
note = "Funding Information: This research was supported by an independent grant from Boehringer Ingelheim Pharmaceuticals, which provided both drug and financial support for the study. ",
year = "2021",
doi = "10.1080/14779072.2021.1842051",
language = "English",
volume = "19",
pages = "101--102",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Taylor and Francis Ltd.",
number = "1",
}